Nemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging Study

Nemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging Study

William A Fahy,1 Farshid Homayoun-Valiani,2 Anthony Cahn,3 Jon Robertson,4 Alison Templeton,4 Wilhelmine H Meeraus,5 Robert Wilson,3 Mike Lowings,6 Miriam Marotti,7 Sarah L West,2 Maggie Tabberer,8 Edith M Hessel9 1Discovery Medicine, GlaxoSmithKline R&D, GSK House, Brentford, UK; 2Global Cl...

Full description

Bibliographic Details
Main Authors: Fahy WA, Homayoun-Valiani F, Cahn A, Robertson J, Templeton A, Meeraus WH, Wilson R, Lowings M, Marotti M, West SL, Tabberer M, Hessel EM
Format: Article
Language:English
Published: Dove Medical Press 2021-06-01
Series:International Journal of COPD
Subjects:
acute exacerbation
copd
dose-ranging
nemiralisib
Online Access:https://www.dovepress.com/nemiralisib-in-patients-with-an-acute-exacerbation-of-copd-placebo-con-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/nemiralisib-in-patients-with-an-acute-exacerbation-of-copd-placebo-con-peer-reviewed-fulltext-article-COPD

Similar Items